Solésence Earns 'Contract Manufacturing Partner of the Year' Award
SLSN sits 71% above its 52-week low of $0.78.
Summary
Solésence was named Contract Manufacturing Partner of the Year in the 2026 Cosmetics Business Innovation Awards, recognizing its excellence in client satisfaction, innovation, and product development. This significant industry award provides a positive operational highlight for the company, which recently reported a net loss of $0.8 million in Q1 2026 and negative operating cash flow for fiscal year 2025. The recognition validates Solésence's core capabilities and could enhance its reputation, potentially attracting new brand partners and improving future business prospects.
At the time of this announcement, SLSN was trading at $1.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $93.9M. The 52-week trading range was $0.78 to $5.63. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: GlobeNewswire.